Nice research by Chanel5. Enrichment is the key to moving these studies and research for Biel with 4 FDA technologies and Electromes platform are now ready to complete the move into neurological pmef applications ala the vagus nerve. Biel's study commenced in early 2024 and their patent application may be under review? I am aligning the dates to highlight how ahead of the curve the company may be. The NDA must be with a large entity with financial resources to cash flow production and another FDA PMA clinical? JMO Do your due diligence before making any investment!

https://www.newmediawire.com/news/bioelectron...ng-7075138